# OnCo record nct07004413 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07004413/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07004413", "NCT07004413" ;
  schema:name "Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients"@en ;
  schema:alternateName "FIRE-11"@en ;
  schema:description "A phase 3 trial in colorectal cancer, run by Charite University, Berlin, Germany, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07004413/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07004413> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:companies <https://onco.cc/companies/guardant-health/>, <https://onco.cc/companies/merck-kgaa/> .